Robocath Launches New Robotic Platform R-One+
Robocath, a company that specializes in designing and developing robotic solutions for the treatment of cardiovascular diseases, has announced the launch of its latest robotic platform, the R-One+. The new solution is designed to digitize endovascular medicine and make percutaneous coronary intervention (PCI) procedures easier and safer.
The R-One+ robotic solution allows interventional cardiologists to perform coronary angioplasties by controlling devices through an integrated control command unit located in the cath lab or control room. This innovative technology offers two main benefits: it protects medical staff from radiation-induced injuries and makes PCI procedures easier and safer. Thanks to R-One+, cardiologists can perform improved hand gestures with even greater precision and in more comfortable working conditions.
According to Dr. Mohammed Nejjari, an interventional cardiologist at the Center Cardiologique du Nord (CCN) in Saint-Dennis, France, “For the first time, I was able to perform multiple robotic angioplasties from the comfort of my chair in the control room, where I was completely protected from X-rays and could do without my lead apron. This new setup has changed the way we organize our procedures and has given nursing staff the opportunity to develop new skills.”
Furthermore, Prof. Michael Haude, interventional cardiologist at Lukaskrankenhaus hospital in Neuss, Germany said that “R-One+ makes it extremely easy to position devices with pinpoint accuracy. It is also much more comfortable to operate with robotic technology, and as the main operator, I am completely shielded from radiation.”
The launch of R-One+ marks a big step forward in digital transformation of cath labs as Robocath continues on its path towards ensuring better care for patients while protecting medical staff. Philippe Bencteux, President and Founder of Robocath said that “I am delighted that we are now launching R-One+; this solution marks a big step forward in the digital transformation of the cath lab as we continue to work towards our goal of ensuring better care for patients and better protection for medical staff.”
The supposition, Robocath’s new robotic platform, R-One+, has revolutionized interventional cardiology by making PCI procedures easier and safer while protecting medical staff from radiation-induced injuries. This innovative technology is expected to play an important role in the transformation of interventional cardiology. According to the article, “R-One+ will mark a new chapter in the history of our field.”